Zachary Klein

Zachary Klein supports clients with evidence-based research and analysis that spans healthcare sectors and stakeholders, contributing to the development of client analysis and insights.

Prior to joining Avalere, Zachary completed an internship with the Blue Cross/Blue Shield Association’s Office of Policy and Representation, working with the Medicare team. Zachary also interned for Wisconsin’s governor, Tony Evers, focusing on the governor’s statewide health policy objectives. As an undergraduate research assistant with the Neidenthal Human Emotions lab, Zachary worked to further understand the underpinnings of the human emotional experience, focusing specifically on mechanisms such as facial expression analysis and the effects of social media on self-worth.

Zachary holds a BA in political science and psychology from the University of Wisconsin-Madison.

Authored Content

An Avalere survey of 37 decision-makers at risk-bearing payer entities identified shifting trends and focus for coverage of and access to behavioral health treatments and services.

Since the beginning of the Public Health Emergency (PHE), manufacturers have been developing monoclonal antibodies (mAbs) and other treatment modalities to prevent and treat COVID-19.

On January 21, the Biden administration released its National Strategy for the COVID-19 Response and Pandemic Preparedness. The plan highlights numerous actions that the administration intends to implement as it assumes responsibility in the fight against COVID-19.

1115 Waivers approved by CMS allow state Medicaid programs to better address substance use disorders among beneficiaries.

The evolution of the US influenza vaccine market offers insights into the potential barriers and opportunities for successful rollouts of novel COVID-19 vaccines.